Your GLP-1 Prescription Is Desk Stakes. Now What?

Digital clinics are superb at getting GLP-1s into sufferers’ palms quick. That chapter is behind us, and the margins are compressing to show IT.

Leaders like Ro, hims & hers, Calibrate and Found have began constructing extra holistic Health options, layering in teaching, CGMs, and behavioral help. That could be a respectable first step. However breadth with out depth isn’t a moat; IT’s a characteristic set. And IT’s solely a matter of time earlier than characteristic units get copied.

Furthermore “holistic” by itself begs the query, “holistic for whom?” The sincere reply is for the “common” affected person, which is to say for the “lowest frequent denominator” or “for nobody particularly.”

Personalization is the lacking hyperlink, and much more particularly, biology-based personalization.

The platforms that may matter in the long term are those that may have a look at a affected person’s phenotype, their biomarkers, their physiology and construct a routine that addresses their distinctive wants. Not a formulaic program however an individualized one.

The science to do that exists. The instruments exist. What a lot of the panorama is lacking are the imaginative and prescient and near-term incentive to maneuver past the present “land seize” surroundings. However for higher or worse, financial actuality is about to pressure the problem.

---

A GLP-1 Tailor-made Vitamin Wraparound

A landmark joint advisory from the American School of Life-style Drugs, the American Society for Vitamin, the Weight problems Drugs Affiliation, and The Weight problems Society put IT plainly: GLP-1s obtain significant weight discount, however they arrive with a set of challenges — gastrointestinal unwanted effects, dietary deficiencies, and vital lack of muscle and bone mass.

Sufferers on GLP-1 remedy who don’t keep enough protein consumption danger sarcopenic weight problems – dropping muscle with out proportionally dropping fats. Throughout main weight discount, consultants suggest protein consumption of 1.2 to 2.0 grams per kilogram of adjusted physique weight per day. Sadly for many GLP-1 sufferers, reaching even baseline protein targets is troublesome as a result of the drug suppresses urge for food so aggressively.

Particularly, over 20% of GLP-1 sufferers are nutritionally poor inside 12 months of initiating remedy. Lack of lean mass, if left unaddressed, will increase long-term danger and erodes the metabolic Health outcomes that made the therapy worthwhile within the first place.

GI unwanted effects compound the issue. Nausea, vomiting, and basic discomfort are key drivers of discontinuation. The implications are clear: maximizing the advantages of GLP-1 remedy requires a multidisciplinary strategy integrating evidence-based vitamin, bodily exercise, and proactive administration of gastrointestinal unwanted effects.

A high-protein, nutrient-dense dietary routine — one which goes past dietitian steering and is constructed across the physiological realities of GLP-1 remedy — is a medical necessity, not an upsell. Digital clinics that fail to offer or accomplice to develop such a wraparound go away their sufferers at real danger of medical hurt, and their companies vulnerable to poor outcomes knowledge, excessive churn, and reputational publicity.

---

The Moat Is Realizing Your Sufferers, Not Medicating Them

The primary technology of digital clinic evolution — including teaching, CGM, behavioral help — was about breadth. The vital subsequent transfer is about depth.

A training module or a CGM add-on doesn’t differentiate you if each competitor can bolt on the identical options. What does differentiate you is the depth and intelligence of the affected person relationship, which requires personalization at a stage that almost all platforms haven’t but reached.

Take into account what precision-based weight problems care may entail. Dr. Andres Acosta and colleagues on the Mayo Clinic have demonstrated that weight problems isn’t a single illness however a heterogeneous one, pushed by distinct organic and behavioral phenotypes. Their analysis identifies 4 core phenotypes: hungry mind (impaired satiation), hungry intestine (impaired satiety), emotional starvation (reward-driven consuming), and gradual burn (decreased metabolic price). Their analysis concluded {that a} phenotype-guided strategy to therapy resulted in 1.75 instances larger weight reduction at one 12 months, with 79% of sufferers dropping greater than 10% of physique weight in comparison with solely 34% within the non-phenotyped group.

This science additionally reframes some of the contested questions in GLP-1 care: how lengthy ought to a affected person keep on the drug? The reply is that IT relies upon. Some sufferers might want to stay on GLP-1 remedy indefinitely to keep up their metabolic Health. Others, as they undertake sustained dietary modifications, construct lean muscle, and deal with the basis behavioral drivers of their weight, could also be candidates for tapering or microdosing as their metabolic resilience rebuilds. And people who take advantage of vital life-style transformations ultimately might be able to go off the treatment fully if their metabolic Health is sufficiently restored.

The vital phrase is might. None of those paths could be decided by a generic protocol or a typical titration schedule. They require steady, biologically grounded evaluation: blood biomarkers, physique composition monitoring, physiological knowledge from wearables, and phenotype-informed medical judgment. While you mix that knowledge infrastructure with AI-driven personalization and the best human experience within the loop, you might have one thing that truly displays how advanced and particular person weight problems actually is. Not simply “take this treatment.” However: right here is your treatment, right here is the protein consumption goal calibrated to your lean physique mass, right here is why your phenotype makes you notably prone to GI unwanted effects and the way your food plan ought to account for IT, right here is how we’ll assess over time whether or not your routine ought to evolve, and wherein route.

The digital clinics that construct towards that mannequin can have one thing opponents can’t simply replicate. The clinics counting on a inflexible protocol can have little greater than a buyer record able to migrate on the first worth change.

Severity of situation, tech fluency, stage of intrinsic motivation all matter right here too. Some shoppers could be profitable with the effectivity of an AI-curated plan. Others will need the accountability and help of a human coach or registered dietician. Greatest-in-class platforms will provide each, and can know which sufferers profit most from which strategy.

---

The Protection Disaster Is a Direct Consequence of One-Dimension-Matches-All Care

Right here is the a part of the story that’s altering quickest, and that digital clinics can’t afford to disregard.

The best way GLP-1s are being prescribed immediately — broadly, reactively, and largely with out individualized medical standards or structured wraparound applications — isn’t a sustainable mannequin for the Health system.

Employers are strolling away from GLP-1 protection at an accelerating price. In line with theHealth-and-benefits/analysis/national-survey-of-employer-sponsored-Health-plans/”> Mercer Nationwide Survey of Employer-Sponsored Health Plans and the Enterprise Group on Health, 67% of huge employers at the moment cowl GLP-1s for weight administration. Of these, solely 72% mentioned they have been more likely to keep that protection into 2027. Blue Cross Blue Protect of Massachusetts stopped masking GLP-1s for weight problems in employer plans, projecting that doing nothing would value near $1 billion this 12 months, practically double its 2025 spend and 7 instances its 2023 prices. HCA Healthcare, which employs greater than 300,000 employees, minimize weight-loss GLP-1 protection fully after use surged 90% in a single 12 months. The information and diagrams under paint a transparent story about the place that is heading.

The issue isn’t merely the price of the medicine; IT’s that protection selections are being made within the absence of the outcomes knowledge that will justify them. When GLP-1s are prescribed with out individualized medical standards, the ROI case for payers turns into troublesome. The result’s blunt, across-the-board protection cuts that harm the sufferers who genuinely want and would profit most from these medicines.

The employers and payers that are persevering with to cowl GLP-1s are attaching circumstances: participation in weight administration applications, verification of medical eligibility by way of biometric knowledge, restrictions on prescribing to particular suppliers. In different phrases, they’re starting to demand proof that the funding will produce outcomes. That’s precisely the best intuition, though the implementation continues to be blunt.

This trajectory factors towards an inevitable reckoning. Payers will more and more wish to reimburse for holistic, outcomes-driven weight problems care, individualized applications that may show adherence, biomarker enchancment, lean mass preservation, and a rational, biology-guided strategy to dosing over time. The digital clinics which have constructed that infrastructure shall be positioned to make the case for his or her sufferers. The remainder shall be preventing a worth warfare on commodity prescriptions and programming with eroding protection help from employers and insurers.

The case for the total routine can also be backed by outcomes knowledge. Analysis monitoring 192,000 GLP-1 customers discovered that people who maintained remedy for 18 months confirmed slower medical value progress and a discount in hospitalizations. The medicine, when supported by the best behavioral and dietary infrastructure, do drive long-term value discount.

---

What an Individualized GLP-1 Program Seems to be Like

The mannequin I’m describing isn’t theoretical. The elements exist. What’s lacking is integration and intentionality.

A digital clinic critical about constructing for the long run ought to be assembling:

A customized dietary plan constructed across the affected person’s protein necessities, GI tolerance, and dietary preferences, with a particular emphasis on protein-enriched, nutrient-dense meals that helps muscle preservation. This isn’t generic wholesome consuming recommendation. IT is a clinically knowledgeable routine that accounts for the physiological realities of GLP-1 remedy.

Biomarker-driven personalization that includes each blood-based knowledge (metabolic panels, inflammatory markers, hormonal profiles) and physiological knowledge from wearables (exercise ranges, sleep high quality, HRV, glucose tendencies the place relevant). This knowledge ought to inform each the therapy plan (together with dosing selections over time) and the continuing measurement of progress.

Phenotype-informed decision-making — drawing on the rising physique of analysis that reveals completely different sufferers reply very in a different way to each the treatment and to particular behavioral and dietary interventions. Understanding which phenotype is driving a affected person’s weight problems modifications the therapy calculus considerably, together with how lengthy they’re more likely to want pharmacological help.

A dynamic dosing framework — moderately than a static prescription, a structured strategy to evaluating whether or not a affected person ought to keep on their present dose, taper, microdose, or doubtlessly transition off the treatment, primarily based on constantly up to date organic and behavioral knowledge. That is the layer that transforms a prescription enterprise into a real medical outcomes enterprise.

Human-AI optionality — an AI-driven expertise for sufferers who need effectivity and self-direction, with pathways to registered dietitians and Health coaches for many who profit from human help and accountability.

Outcomes monitoring that goes past the dimensions — capturing lean muscle mass preservation, biomarker enchancment, and adherence metrics that may be shared with employers and payers to construct the proof base for holistic reimbursement.

---

The Strategic Crucial

The GLP-1 market is right here to remain. Whilst employer protection contracts, the affected person inhabitants in search of these therapies continues to develop, and the medical proof for his or her efficacy stays robust. Newer oral formulations will develop entry additional.

However the digital clinic class is about to bifurcate. The Losers: commodity prescription platforms that win on worth and comfort till they don’t, squeezed by protection pullbacks, excessive churn, and undifferentiated positioning. The Winners: platforms which have invested within the full-spectrum affected person relationship — personalised vitamin, biomarker intelligence, phenotype-informed care, dynamic dosing, and demonstrable outcomes.

---

About Jon Michaeli

Jon Michaeli is the Sr. GTM & Business Advisor & Advisor at InsideTracker. He’s a go-to-market and business operator with 25+ years turning science-backed Health and wellness merchandise into repeatable income. As Sr. GTM & Business Advisor at InsideTracker, he at the moment leads the corporate’s enlargement from DTC to B2B, together with the launch of its Terra(TM) Health AI platform for shopper Health companies. His management profession spans senior business roles at Medisafe—the place he grew the person base from 800K to 4M+—Zipline, Matternet, Vista.ai, and Sleep Quantity. An energetic angel investor in ~70 Health and MedTech firms, Jon holds an MBA from UCLA Anderson and a BA in Economics from Tufts.